Context Therapeutics Inc. financial data

Symbol
CNTX on Nasdaq
Location
2001 Market Street, Suite 3915 Unit #15, Philadelphia, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.15K % +168%
Debt-to-equity 3.38 % -63.6%
Return On Equity -38.8 % +27%
Return On Assets -37.5 % +22.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 89.7M shares +19.6%
Common Stock, Shares, Outstanding 89.7M shares +19.6%
Common Stock, Value, Issued 89.7K USD +19.6%
Weighted Average Number of Shares Outstanding, Basic 95.2M shares +73.2%
Weighted Average Number of Shares Outstanding, Diluted 95.2M shares +73.2%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 7.66M USD +11.4%
Operating Income (Loss) -38.3M USD -91.3%
Net Income (Loss) Attributable to Parent -34.2M USD -84.2%
Earnings Per Share, Basic 0 USD/shares +68.9%
Earnings Per Share, Diluted 0 USD/shares +68.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.5M USD -17.7%
Assets, Current 86.9M USD -15.3%
Property, Plant and Equipment, Net 37.8K USD +264%
Operating Lease, Right-of-Use Asset 166K USD
Assets 87.2M USD -15.1%
Accounts Payable, Current 2.4M USD +292%
Employee-related Liabilities, Current 865K USD +96.3%
Accrued Liabilities, Current 2.04M USD +106%
Liabilities, Current 4.56M USD +184%
Operating Lease, Liability, Noncurrent 52.3K USD
Liabilities 4.61M USD +187%
Retained Earnings (Accumulated Deficit) -108M USD -46.2%
Stockholders' Equity Attributable to Parent 82.5M USD -18.4%
Liabilities and Equity 87.2M USD -15.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 200M shares +100%
Common Stock, Shares, Issued 89.7M shares +19.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 83.5M USD -17.7%
Operating Lease, Liability 200K USD
Operating Lease, Liability, Current 115K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 191M USD +8.93%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1.13M USD +24.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%